Navigation Links
Poniard Pharmaceuticals Announces Progression-Free Survival Data From Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer
Date:5/28/2009

nths for those who received modified FOLFOX-6, containing oxaliplatin.
  • Of the 51 patients in the FOLPI treatment arm, 75 percent achieved disease control (defined as complete response, partial response or stable disease); two patients with a complete response, nine patients with a partial response and 27 patients with stable disease. In the FOLFOX treatment arm of 50 patients, 76 percent achieved disease control; three patients with a complete response, 11 patients with a partial response and 24 patients with stable disease.
  • Only 29 percent of the patients who received FOLPI showed evidence of neurotoxicity compared with 60 percent of patients treated with FOLFOX. In addition, 16 percent of FOLFOX-treated patients exhibited severe (Grade 3/4) neurotoxicity, whereas no FOLPI-treated patients showed evidence of severe neurotoxicity. Three different measurements of neuropathy were statistically significant for FOLPI as a potential neuropathy-sparing alternative to FOLFOX (p<0.0019).
  • With regard to hematologic toxicities, thrombocytopenia and neutropenia were more frequent and severe with the FOLPI regimen compared with FOLFOX. However, only one episode of febrile neutropenia and no bleeding complications have been observed to date. In addition, 83 percent of the planned picoplatin dose of 150 mg/meter squared was able to be delivered monthly in the 51 patients treated in the FOLPI treatment arm of the trial.
  • Nonhematologic adverse events, including gastrointestinal toxicity, were similar between the treatment groups, with the exception of alopecia, which occurred more frequently with FOLPI.

  • "We continue to be encouraged by these interim, proof-of-concept Phase 2 safety and efficacy results, which suggest the potential of picoplatin in FOLPI as a neuropathy-sparing therapeutic alternative to the use of FOLFOX for the first-line treatment of metast
    '/>"/>

    SOURCE Poniard Pharmaceuticals, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update
    2. Poniard Pharmaceuticals to Present New Data from Phase 2 Clinical Trials of Picoplatin in Multiple Tumor Types at the 45th Annual Meeting of the American Society of Clinical Oncology
    3. Poniard Completes Patient Enrollment Target in Phase 3 SPEAR Trial of Picoplatin in Small Cell Lung Cancer
    4. Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update
    5. Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin
    6. Poniard Pharmaceuticals Announces Final Top-Line Results from Phase 1 Trial Demonstrating Positive Bioavailability with Oral Picoplatin
    7. Poniard Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer
    8. Poniard Announces Positive Preliminary Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in First-Line Treatment of Colorectal Cancer
    9. Poniard Announces Positive First-Line Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in Patients with Metastatic Hormone Refractory Prostate Cancer
    10. Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting
    11. Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/24/2014)... , July 24, 2014  Parnell Pharmaceuticals ... compounds that will be added to Parnell,s already ... CIMTECH Pty Ltd, a biotechnology company. The compounds ... have shown promise in bone regeneration and dermal ... develop the compounds for the veterinary market with ...
    (Date:7/24/2014)... 2014  PTC Therapeutics, Inc. (NASDAQ: PTCT ... webcast conference call to report its second quarter 2014 ... business and outlook on Thursday, August 7, 2014 at ... The call can be accessed by ... minutes prior to the start of the call and ...
    (Date:7/24/2014)... 2014  Restore Health, a leading personalized medicine ... that it is now offering pharmacogenetics testing that ... based upon their particular genetic makeup. Comprehensive medication ... between a patient,s genetics and their entire drug ... provide this new service to healthcare providers and ...
    Breaking Medicine Technology:Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 2Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 3Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 4Restore Health Launches Pharmacogenetic Testing, Enhancing Its Suite of Personalized Medicine Goods and Services 2Restore Health Launches Pharmacogenetic Testing, Enhancing Its Suite of Personalized Medicine Goods and Services 3
    ... Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ ) announced today that Bruce Cozadd ... 35th Annual Health Care Conference on Monday, May 3, 2010 at ... Boston, MA. , , , ... of the presentation may be accessed from the Investors section of the Jazz ...
    ... April 26 Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH ), a ... announced Paul F. Truex , Anthera,s President and Chief Executive Officer ... Boston, MA on Monday, May 3, 2010 at ... , , ...
    Cached Medicine Technology:Anthera Pharmaceuticals to Present at Deutsche Bank Securities' 35th Annual Health Care Conference 2
    (Date:7/24/2014)... one of the most reliable online dress suppliers by ... its new and old customers with the latest designs ... its new collection of high end wedding dresses. Each ... the latest fashion trends. Additionally, they are now provided ... a matter of fact, high end special occasion outfits ...
    (Date:7/24/2014)... (PRWEB) July 24, 2014 Ticket Down ... Roma Tickets in Denver at the Sports Authority Field on ... (or World Football Challenge) has brought some of the best club ... With the World Cup still being raved about weeks after its ... chance to see some of the biggest stars in the world ...
    (Date:7/24/2014)... Research Triangle Park, NC (PRWEB) July 24, 2014 ... the elderly, ethnic minorities, and low-income households are ... private and public food safety net in the ... RTI International. , Under Section 743 of the ... the U.S. Department of Agriculture's Food and Nutrition ...
    (Date:7/24/2014)... July 25, 2014 The report, ... the CDN market into various sub-segments with an ... identifies the drivers and restraints for this market ... Browse 93 market data tables and 36 figures ... “Content Delivery Networks (CDN) Market” at http://www.marketsandmarkets.com/Market-Reports/content-delivery-networks-cdn-market-657.html ...
    (Date:7/24/2014)... Maui, HI (PRWEB) July 24, 2014 ... the completion this month of its $3 million renovation ... the new Lokelani presidential/residential three-bedroom suites, just in time ... in Maui. , With design direction from the internationally-acclaimed ... Resort suites—the largest on the property and the largest ...
    Breaking Medicine News(10 mins):Health News:BellasDress Helps Brides Get High End Wedding Dresses for Their Romantic Weddings 2Health News:Manchester United vs. AS Roma Tickets Denver Sports Authority Field at Mile High: Ticket Down Cuts Ticket Prices for Guinness International Champions Cup Match 2Health News:Manchester United vs. AS Roma Tickets Denver Sports Authority Field at Mile High: Ticket Down Cuts Ticket Prices for Guinness International Champions Cup Match 3Health News:Report: Vulnerable Populations Disproportionately Affected by Food Security, Despite Public Programs 2Health News:Report: Vulnerable Populations Disproportionately Affected by Food Security, Despite Public Programs 3Health News:CDN Market by Delivery Technologies & Solutions Expected to Reach $12.16 Billion by 2019 - New Report by MarketsandMarkets 2Health News:CDN Market by Delivery Technologies & Solutions Expected to Reach $12.16 Billion by 2019 - New Report by MarketsandMarkets 3Health News:CDN Market by Delivery Technologies & Solutions Expected to Reach $12.16 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Four Seasons Resort Maui's Newly Designed Top Suites Debut 2Health News:Four Seasons Resort Maui's Newly Designed Top Suites Debut 3Health News:Four Seasons Resort Maui's Newly Designed Top Suites Debut 4Health News:Four Seasons Resort Maui's Newly Designed Top Suites Debut 5
    ... related to aggressive cancers can actually improve the efficacy ... Priority Report in Cancer Research , published by ... Hu antigen R (HuR), is a stress response protein ... certain experimental settings, pancreatic cancer cells that overexpressed HuR ...
    ... ... receives U.S. FDA Approval , ... (Vocus) June 4, 2009-- A new wrinkle-smoother will be arriving in doctors, ... in the European Union, Brazil, Argentina and more than 26 countries worldwide is a ...
    ... Free Webcast on Making a Smooth Transition to the EMR ... (NYSE: IRM ), the global leader in information ... tips during an upcoming Webcast for how healthcare providers can ... In this free, hour-long Webcast, attendees will learn the chief ...
    ... Better diagnosis, treatments behind decrease, researchers say , WEDNESDAY, June ... to fewer deaths from the rupture of a blood vessel ... Known as a subarachnoid hemorrhage, this kind of rupture leads ... thin tissue that covers the brain. It can occur spontaneously, ...
    ... Information Exchange for Medicaid Beneficiaries, Powered by MedPlus Centergy(TM) ... Access to Patient Information and Better Health Outcomes , ... The Department of Health Care Finance, DHCF, the District,s ... information technology subsidiary of Quest Diagnostics Incorporated (NYSE: ...
    ... following was released today by 1st Class Kids: , ... Tournament to raise money in support of continued obesity ... filled with TopGolf Skills Challenges, game play, live entertainment, ... the need to raise awareness about childhood obesity. Additionally, ...
    Cached Medicine News:Health News:Jefferson researchers identify critical marker of response to gemcitabine in pancreatic cancer 2Health News:New Option for Erasing Wrinkles 2Health News:New Option for Erasing Wrinkles 3Health News:New Option for Erasing Wrinkles 4Health News:Best Practices for Hospitals Moving to Electronic Medical Records 2Health News:Fewer Deaths Occurring From Brain Bleeds 2Health News:Health Care Finance to Implement District's First Medicaid 'Patient Data Hub' Using MedPlus Technology 2Health News:Health Care Finance to Implement District's First Medicaid 'Patient Data Hub' Using MedPlus Technology 3Health News:Health Care Finance to Implement District's First Medicaid 'Patient Data Hub' Using MedPlus Technology 4
    The automated and pivoting M2 hand-piece incorporates two powerful, independent electric motors : one controls the blade oscillation at 15,000 RPM and the second controls the high-torque advance of t...
    ... potential for quality vision with ACRYSOF IQ ... spherical aberration by addressing the effects of ... without increasing edge thickness. Human corneal ... that provides improved image quality.,MTF (measured in ...
    ... Advanced Optics Aspheric Lens System can ... IOL all your cataract patients will ... quality and contrast sensitivity. With a ... should consistently deliver superior optical performance ...
    ... was designed to be as easy to ... shares many of its features, including CPR ... HeartStart Home Defibrillator is an automated external ... use by untrained users. Although small and ...
    Medicine Products: